Status:
COMPLETED
Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
50+ years
Brief Summary
The aim of the study is to investigate the existence of clonal hematopoiesis of indeterminate potential (CHIP) in patients with a history of venous thromboembolism. The study investigators make the a...
Eligibility Criteria
Inclusion
- Men and women over 50 years old who have consulted at the Hematology laboratory of the Nîmes University Hospital for the occurrence or history of venous thromboembolism
- Patient who has accepted that their DNA was kept and used in the context of research on venous thromboembolism (biobank (registration number DC-2008-290 and authorization number AC-2008-107))
Exclusion
- Patients less than 50 years old
- Patient who has refused that their DNA was kept and used in the context of research on venous thromboembolism
Key Trial Info
Start Date :
July 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04477564
Start Date
July 3 2020
End Date
June 13 2023
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nimes
Nîmes, France